Clotting factors to treat thrombolysis-related symptomatic intracranial hemorrhage in acute ischemic stroke

Journal of Stroke and Cerebrovascular Diseases

Volumn 23, Issue 3, 2014, Pages

  Alderazi, Yazan J ^a   Barot, Niravkumar V ^a   Peng, Hui ^b   Vahidy, Farhaan S ^a   Navalkele, Digvijaya D ^a   Sangha, Navdeep ^a   Misra, Vivek ^a   Savitz, Sean I ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

acute ischemic stroke; Cerebrovascular disease; fresh frozen plasma; stroke; symptomatic intracranial hemorrhage; thrombolysis

Indexed keywords

BLOOD CLOTTING FACTOR; FRESH FROZEN PLASMA; TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; BLOOD CLOT LYSIS; BLOOD TRANSFUSION; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; COHORT ANALYSIS; CONSERVATIVE TREATMENT; CRYOPRECIPITATE; DEATH; DIABETES MELLITUS; FOLLOW UP; HEMATOMA; HUMAN; IMMOBILITY; MAJOR CLINICAL STUDY; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; RANKIN SCALE; RETROSPECTIVE STUDY; THROMBOCYTE TRANSFUSION; UNITED STATES;

ACUTE ISCHEMIC STROKE; CEREBROVASCULAR DISEASE; FRESH FROZEN PLASMA; STROKE; SYMPTOMATIC INTRACRANIAL HEMORRHAGE; THROMBOLYSIS;

AGED; AGED, 80 AND OVER; BLOOD COAGULATION; BRAIN ISCHEMIA; COAGULANTS; FEMALE; FIBRINOLYTIC AGENTS; HOSPITALS, UNIVERSITY; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; TEXAS; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84896342103     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2013.10.009     Document Type: Article

References (27)

1. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group N Engl J Med 333 1995 1581 1587
2. W. Hacke, M. Kaste, and E. Bluhmki et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke N Engl J Med 359 2008 1317 1329
3. A. Furlan, R. Higashida, and L. Wechsler et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism JAMA 282 1999 2003 2011
4. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease Stroke 40 2009 2761 2768
5. W.S. Smith, G. Sung, and J. Saver et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial Stroke 39 2008 1205 1212
6. A.C. Flint, G.R. Duckwiler, and R.F. Budzik et al. Mechanical thrombectomy of intracranial internal carotid occlusion: pooled results of the MERCI and Multi MERCI Part I trials Stroke 38 2007 1274 1280
7. D.L. Brown, W.G. Barsan, and L.D. Lisabeth et al. Survey of emergency physicians about recombinant tissue plasminogen activator for acute ischemic stroke Ann Emerg Med 46 2005 56 60
8. N. Wahlgren, N. Ahmed, and A. Davalos et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study Lancet 369 2007 275 282
9. N. Wahlgren, N. Ahmed, and A. Davalos et al. Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study Lancet 372 2008 1303 1319
10. D. Strbian, T. Sairanen, and A. Meretoja et al. Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis Neurology 77 2011 341 348
11. G.W. Albers, V.N. Thijs, and L. Wechsler et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study Ann Neurol 60 2006 508 517
12. S.M. Davis, G.A. Donnan, and M.W. Parsons et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial Lancet Neurol 7 2008 299 309
13. L.C. Souza, S. Payabvash, and Y. Wang et al. Admission CT perfusion is an independent predictor of hemorrhagic transformation in acute stroke with similar accuracy to DWI Cerebrovasc Dis 33 2012 8 15
14. J.N. Goldstein, M. Marrero, and S. Masrur et al. Management of thrombolysis-associated symptomatic intracerebral hemorrhage Arch Neurol 67 2010 965 969
15. M. Fiorelli, S. Bastianello, and R. von Kummer et al. Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort Stroke 30 1999 2280 2284
16. R.C. Seet, and A.A. Rabinstein Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions Cerebrovasc Dis 34 2012 106 114
17. J.C. Hemphill III, D.C. Bonovich, and L. Besmertis et al. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage Stroke 32 2001 891 897
18. J.P. Broderick, T.G. Brott, and J.E. Duldner et al. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality Stroke 24 1993 987 993
19. G.A. Christoforidis, A. Slivka, and Y. Mohammad et al. Size matters: hemorrhage volume as an objective measure to define significant intracranial hemorrhage associated with thrombolysis Stroke 38 2007 1799 1804
20. R.U. Kothari, T. Brott, and J.P. Broderick et al. The ABCs of measuring intracerebral hemorrhage volumes Stroke 27 1996 1304 1305
21. K.A. Knudsen, J. Rosand, and D. Karluk et al. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria Neurology 56 2001 537 539
22. J.L. Saver Hemorrhage after thrombolytic therapy for stroke: the clinically relevant number needed to harm Stroke 38 2007 2279 2283
23. P. Sandercock, J.M. Wardlaw, and R.I. Lindley et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (The Third International Stroke Trial [IST-3]): a randomised controlled trial Lancet 379 2012 2352 2363
24. D. Dowlatshahi, A.M. Demchuk, and M.L. Flaherty et al. Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes Neurology 76 2011 1238 1244
25. H.P. Adams Jr., P.H. Davis, and E.C. Leira et al. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST) Neurology 53 1999 126 131
26. G.C. Fonarow, J.L. Saver, and E.E. Smith et al. Relationship of national institutes of health stroke scale to 30-day mortality in medicare beneficiaries with acute ischemic stroke J Am Heart Assoc 1 2012 42 50
27. M.N. Diringer, D.F. Edwards, and A.R. Zazulia Hydrocephalus: a previously unrecognized predictor of poor outcome from supratentorial intracerebral hemorrhage Stroke 29 1998 1352 1357